Table 3.
AEs by Preferred Term | Number of patients (N = 10) | ||
---|---|---|---|
Any grade | Grade 3 | Grade 4 | |
Leukopenia/white blood cell count decreased | 10 | 0 | 10 |
Lymphopenia/lymphocyte count decreased | 10 | 0 | 10 |
Neutropenia/neutrophil count decreased | 10 | 0 | 10 |
Anemia/red blood cell count decreased | 9 | 9 | 0 |
Thrombocytopenia/platelet count decreased | 6 | 1 | 4 |
Hyponatremia | 6 | 5 | 0 |
Hypophosphatemia | 4 | 1 | 1 |
Fatigue | 7 | 2 | 0 |
Tumor pain | 3 | 2 | 0 |
Rash | 5 | 0 | 1 |
Pyrexia | 6 | 1 | 0 |
Decreased appetite | 5 | 1 | 0 |
Constipation | 4 | 1 | 0 |
Hypotension | 4 | 1 | 0 |
Hypocalcemia | 3 | 1 | 0 |
Abdominal pain | 2 | 1 | 0 |
Acute kidney injury | 2 | 1 | 0 |
CRS | 2 | 1 | 0 |
Dyspnea | 2 | 1 | 0 |
AE, adverse event; CRS, cytokine release syndrome; mITT, modified intent-to-treat.